Results 1 to 10 of about 33,864 (191)

Renal Transplantation in Pure Autonomic Failure [PDF]

open access: goldTransplantation Direct, 2022
Zain Ul Abideen, MRCP, UK   +5 more
doaj   +5 more sources

Multimodal Autonomic Biomarkers Predict Phenoconversion in Pure Autonomic Failure [PDF]

open access: goldAnnals of Clinical and Translational Neurology
Background Pure autonomic failure (PAF) presents with autonomic failure without other neurological features. A third develop central neurological features, fulfilling criteria for multiple system atrophy (MSA) and Lewy body diseases (LBD), including ...
S. Koay   +12 more
doaj   +5 more sources

A Case of Pure Autonomic Failure Initially Presenting with Hemihypohidrosis: Twelve-Year Follow-Up [PDF]

open access: goldCase Reports in Neurology, 2022
Although it is generally recognized that pure autonomic failure (PAF) is a progressive neurodegenerative disease selectively involving the autonomic nervous system, its mode of progression remains to be settled.
Hiroshi Saito
doaj   +4 more sources

Relationships Between Cardiovascular Autonomic Profile and Work Ability in Patients With Pure Autonomic Failure [PDF]

open access: goldFrontiers in Human Neuroscience, 2021
Pure autonomic failure (PAF) is a rare disorder belonging to the group of synucleinopathies, characterized by autonomic nervous system degeneration.
Antonio R. Zamunér   +12 more
doaj   +4 more sources

Pure Autonomic Failure. [PDF]

open access: bronzeMayo Clin Proc, 2019
Pure autonomic failure (PAF) is a neurodegenerative disorder of the autonomic nervous system clinically characterized by orthostatic hypotension. The disorder has also been known as Bradbury-Eggleston syndrome, named for the authors of the 1925 seminal description.
Coon EA, Singer W, Low PA.
europepmc   +8 more sources

Cardiac sympathetic innervation and vesicular storage in pure autonomic failure [PDF]

open access: goldAnnals of Clinical and Translational Neurology, 2020
Objective Pure autonomic failure (PAF) is a rare disease characterized by neurogenic orthostatic hypotension (nOH), absence of signs of central neurodegeneration, and profound deficiency of the sympathetic neurotransmitter norepinephrine.
David S. Goldstein   +4 more
doaj   +3 more sources

Autonomic ganglionic injection of α-synuclein fibrils as a model of pure autonomic failure α-synucleinopathy [PDF]

open access: goldNature Communications, 2020
Autonomic dysfunction is a feature of some α-synucleinopathies, but there are no models of pure autonomic dysfunction associated with α-synuclein.
Xue-Jing Wang   +10 more
doaj   +4 more sources

Pure Autonomic Failure with Asymptomatic Hypertensive Urgency: A Case Report and Literature Review [PDF]

open access: goldCase Reports in Neurology, 2018
We report the case study of a 70-year-old gentleman who presented with isolated, slowly progressive dizziness after prolonged standing and was eventually diagnosed with pure autonomic failure.
Alwaleed Aljohar   +5 more
doaj   +4 more sources

Predicting phenoconversion in pure autonomic failure. [PDF]

open access: greenNeurology, 2020
To determine predicting factors and frequency of phenoconversion from pure autonomic failure (PAF) into a synucleinopathy with motor or cognitive involvement of multiple system atrophy (MSA), Parkinson disease (PD), or dementia with Lewy bodies (DLB).We performed a retrospective review of all patients with PAF from 2001 to 2011 evaluated at Mayo Clinic,
Coon EA   +6 more
europepmc   +6 more sources

Renal impairment of pure autonomic failure. [PDF]

open access: bronzeHypertension, 2009
Supine hypertension is difficult to manage in patients with pure autonomic failure (PAF), because treatment can worsen orthostatic hypotension. Supine hypertension in PAF has been associated with left ventricular hypertrophy, but end organ damage in the kidney has not been assessed.
Garland EM   +7 more
europepmc   +6 more sources

Home - About - Disclaimer - Privacy